Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124230) titled 'A Pivotal Clinical Trial of human induced pluripotent stem cell-derived cardiomyocytes injection (HiCM-188) for the treatment of Advanced Heart Failure(NYHA III-IV)' on May 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Teda International Cardiovascular Hospital, Chinese Academy of Medical Sciences Peking Union Medical College
Condition:
Advanced Heart Failure
Intervention:
Trial Group:Conventional coronary artery bypass grafting (CABG) combined with intramyocardial injection of human iPSC-derived cardiomyocyte injection fluid (HiCM-188), dose of 1.5x10^6 cells per injection, f...